Literature DB >> 34755673

[MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells].

Y Hu1, D Liang2, X Chen1, L Chen1, J Bai1, H Li3, C Yin4, W Zhong2.   

Abstract

OBJECTIVE: To explore the role of miR-671-5p in regulating the migration and invasion of osteosarcoma and the underlying mechanisms.
METHODS: The differentially expressed microRNAs (miRNAs) in osteosarcoma were screened in the NCBI online database, and the target proteins of these miRNAs were predicted and their functions were analyzed. Osteosarcoma cells were transfected with a plasmid overexpressing miR-671-5p, and the transfection efficiency was assessed using quantitative real-time PCR (qRT-PCR). The changes in the migration and invasion of the transfected cells were examined with Transwell assay, and the expressions of proteins related with epithelial-mesenchymal transition (EMT) were detected using Western blotting. Dual-luciferase reporter assay was performed to determine whether the 3'UTR of SMAD3 contained a targeted binding site of miR-671-5p.
RESULTS: MiR-671-5p was significantly down-regulated in both osteosarcoma tissues and osteosarcoma cells (P < 0.05). The osteosarcoma cells overexpressing miR-671-5p showed significantly reduced migration and invasion abilities (P < 0.05) with obviously lowered expressions of EMT-related proteins (P < 0.05). SMAD3 was highly expressed in osteosarcoma cells (P < 0.05), and dual-luciferase reporter assay confirmed the presence of a targeted binding site between miR-671-5p and the 3'UTR of SMAD3 (P < 0.05). In osteosarcoma cells transfected with a SMAD3-overexpressing plasmid (P < 0.05), the high expression of SMAD3 significantly inhibited by miR-671-5p overexpression (P < 0.05). Transwell assay demonstrated that SMAD3 overexpression significantly promoted the migration and invasion of osteosarcoma cells (P < 0.05), and while miR-671-5p overexpression obviously reversed this effect (P < 0.05).
CONCLUSION: MiR-671-5p can inhibit the invasion and migration of osteosarcoma cells by negatively regulating SMAD3.

Entities:  

Keywords:  SMAD3; epithelial-mesenchymal transition; invasion; miR-671-5p; migration; osteosarcoma

Mesh:

Substances:

Year:  2021        PMID: 34755673      PMCID: PMC8586867          DOI: 10.12122/j.issn.1673-4254.2021.10.16

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

Review 1.  Multidisciplinary approach to osteosarcoma.

Authors:  A Biazzo; M De Paolis
Journal:  Acta Orthop Belg       Date:  2016-12       Impact factor: 0.500

2.  Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells.

Authors:  Rutusmita Mishra; Sandip Nathani; Ritu Varshney; Debabrata Sircar; Partha Roy
Journal:  Mol Biol Rep       Date:  2020-10-19       Impact factor: 2.316

3.  MicroRNA-761 suppresses tumor progression in osteosarcoma via negatively regulating ALDH1B1.

Authors:  Xin Wang; Chao Li; Weitao Yao; Zhichao Tian; Zhiyong Liu; Hong Ge
Journal:  Life Sci       Date:  2020-10-06       Impact factor: 5.037

4.  Osteosarcoma of the jaw: Challenges in the diagnosis and treatment.

Authors:  Mohamed Atef ElKordy; Tarek Sherif ElBaradie; Hisham Ismael ElSebai; Sheriff Mohamed KhairAlla; Ayman Abd ElWahab Amin
Journal:  J Egypt Natl Canc Inst       Date:  2018-02-26

Review 5.  Epithelial Mesenchymal Transition in Tumor Metastasis.

Authors:  Vivek Mittal
Journal:  Annu Rev Pathol       Date:  2018-01-24       Impact factor: 23.472

6.  miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.

Authors:  Gentao Fan; Zhiwei He; Lili Cao; Xin Shi; Sujia Wu; Guangxin Zhou
Journal:  Front Biosci (Landmark Ed)       Date:  2019-06-01

7.  Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.

Authors:  Diana Zabini; Elise Granton; Yijie Hu; Maria Zena Miranda; Ulrike Weichelt; Sandra Breuils Bonnet; Sébastien Bonnet; Nicholas W Morrell; Kim A Connelly; Steeve Provencher; Bahil Ghanim; Walter Klepetko; Andrea Olschewski; Andras Kapus; Wolfgang M Kuebler
Journal:  Am J Respir Crit Care Med       Date:  2018-01-15       Impact factor: 21.405

8.  Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.

Authors:  Patrick Ming-Kuen Tang; Shuang Zhou; Xiao-Ming Meng; Qing-Ming Wang; Chun-Jie Li; Guang-Yu Lian; Xiao-Ru Huang; Yong-Jiang Tang; Xin-Yuan Guan; Bryan Ping-Yen Yan; Ka-Fai To; Hui-Yao Lan
Journal:  Nat Commun       Date:  2017-03-06       Impact factor: 14.919

9.  miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN.

Authors:  Ming He; Peng Shen; Chuang Qiu; Jiashi Wang
Journal:  Aging (Albany NY)       Date:  2019-08-14       Impact factor: 5.682

10.  Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular sponge.

Authors:  Hongli Li; Qingjie Mu; Guoxin Zhang; Zhixin Shen; Yuanyuan Zhang; Jun Bai; Liping Zhang; Dandan Zhou; Quan Zheng; Lihong Shi; Wenxia Su; Chonggao Yin; Baogang Zhang
Journal:  Cell Death Dis       Date:  2020-12-11       Impact factor: 8.469

View more
  2 in total

1.  Circ_0001658 regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and affects the progress of papillary thyroid carcinoma.

Authors:  Xiaoyu Liu; Congren Wang; Zijian Su; Shaoyang Cai; Qunxiong Pan; Xiangjin Chen
Journal:  Ann Transl Med       Date:  2022-09

2.  Prostate Cancer Secretome and Membrane Proteome from Pten Conditional Knockout Mice Identify Potential Biomarkers for Disease Progression.

Authors:  Nilton J Santos; Ana Carolina Lima Camargo; Hernandes F Carvalho; Luis Antonio Justulin; Sérgio Luis Felisbino
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.